Insmed Inc (INSM)
68.15
-0.17
(-0.25%)
USD |
NASDAQ |
Nov 04, 16:00
68.45
+0.30
(+0.44%)
After-Hours: 20:00
Insmed Price to Book Value: 25.22 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 25.22 |
| November 01, 2024 | 25.28 |
| October 31, 2024 | 24.90 |
| October 30, 2024 | 26.01 |
| October 29, 2024 | 26.26 |
| October 28, 2024 | 26.63 |
| October 25, 2024 | 26.26 |
| October 24, 2024 | 26.53 |
| October 23, 2024 | 26.62 |
| October 22, 2024 | 27.26 |
| October 21, 2024 | 26.74 |
| October 18, 2024 | 27.58 |
| October 17, 2024 | 27.48 |
| October 16, 2024 | 28.36 |
| October 15, 2024 | 27.62 |
| October 14, 2024 | 27.78 |
| October 11, 2024 | 27.58 |
| October 10, 2024 | 26.53 |
| October 09, 2024 | 25.88 |
| October 08, 2024 | 26.40 |
| October 07, 2024 | 26.08 |
| October 04, 2024 | 26.74 |
| October 03, 2024 | 26.42 |
| October 02, 2024 | 27.01 |
| October 01, 2024 | 26.96 |
| Date | Value |
|---|---|
| September 30, 2024 | 27.01 |
| September 27, 2024 | 320.87 |
| September 26, 2024 | 322.60 |
| September 25, 2024 | 322.00 |
| September 24, 2024 | 321.54 |
| September 23, 2024 | 317.95 |
| September 20, 2024 | 328.53 |
| September 19, 2024 | 331.90 |
| September 18, 2024 | 322.60 |
| September 17, 2024 | 324.33 |
| September 16, 2024 | 324.19 |
| September 13, 2024 | 330.52 |
| September 12, 2024 | 327.20 |
| September 11, 2024 | 322.11 |
| September 10, 2024 | 316.84 |
| September 09, 2024 | 317.95 |
| September 06, 2024 | 314.50 |
| September 05, 2024 | 322.78 |
| September 04, 2024 | 333.14 |
| September 03, 2024 | 324.52 |
| August 30, 2024 | 338.54 |
| August 29, 2024 | 337.92 |
| August 28, 2024 | 338.80 |
| August 27, 2024 | 341.37 |
| August 26, 2024 | 332.96 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.681
Minimum
Mar 23 2020
349.78
Maximum
Aug 22 2024
38.61
Average
11.38
Median
Dec 14 2020
Price to Book Value Benchmarks
| Fulcrum Therapeutics Inc | 0.743 |
| Alnylam Pharmaceuticals Inc | 1076.09 |
| Eli Lilly and Co | 53.74 |
| Bioventus Inc | 5.911 |
| Entrada Therapeutics Inc | 1.536 |
Price to Book Value Related Metrics
| PS Ratio | 30.89 |
| PEG Ratio | -2.311 |
| Price | 68.15 |
| Earnings Yield | -8.14% |
| Market Cap | 12.19B |
| PEGY Ratio | -2.311 |